Shenzhen's Development and Reform Bureau, in collaboration with the Kexin Bureau, has released the "11th Five-Year Plan for the Development of the Biopharmaceutical Industry in Shenzhen," marking a significant step toward strengthening the city's biotech sector. This initiative aims to boost the growth of the biopharmaceutical industry, with an ambitious target of reaching an annual gross output value of 70 billion to 100 billion yuan by 2010. This is believed to be the first official plan specifically dedicated to developing the biomedical industry in Shenzhen.
According to an official from the Shenzhen Municipal Development and Reform Bureau, the construction of the national biotechnology industrial base in Shenzhen is progressing steadily. A joint coordination meeting has already been established, and further efforts will focus on enhancing the professional service platform, optimizing the policy environment, and increasing government investment in the biopharmaceutical sector.
A total of 30 million yuan has been allocated as part of the Shenzhen High-Tech Industrialization Demonstration Project Plan, aimed at supporting the development of biomedical and medical device industries. The funding will be used to assist local enterprises in promoting independent innovation, expanding into international markets, and contributing to the national bio-industry base construction. Additionally, special funds will be increased annually based on the industry's growth, ensuring continued support for key projects and initiatives in the biopharmaceutical field.
Car Modification Parts,Car Interior Door Handle Cover,Toyota Car Door Handle Cover,Silver Car Door Handle Cover
Changzhou Saina Automobile Industry Co., Ltd , https://www.jsczsaina.com